![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/00 | |
A61K 31/395 | |||
A61K 31/165 | |||
A61P 7/06 |
(11) | Number of the document | 1633333 |
(13) | Kind of document | T |
(96) | European patent application number | 04754383.0 |
Date of filing the European patent application | 2004-06-04 | |
(97) | Date of publication of the European application | 2006-03-15 |
(45) | Date of publication and mention of the grant of the patent | 2014-08-20 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2004/017772 |
Date | 2004-06-04 |
(87) | Number | WO 2004/108121 |
Date | 2004-12-16 |
(30) | Number | Date | Country code |
476704 P | 2003-06-06 | US | |
566488 P | 2004-04-29 | US | |
566237 P | 2004-04-29 | US | |
569797 P | 2004-05-10 | US | |
861590 | 2004-06-03 | US |
(72) |
KLAUS, Stephen, J., US
MOLINEAUX, Christopher, J., US
NEFF, Thomas, B., US
GUENZLER-PUKALL, Volkmar, US
LANSETMO PAROBOK, Ingrid, US
SEELEY, Todd, W., US
STEPHENSON, Robert, C., US
|
(73) |
Fibrogen, Inc.,
409 Illinois Street, San Francisco, CA 94158,
US
|
(54) | USE OF HIF ALPHA STABILIZERS FOR ENHANCING ERYTHROPOIESIS |
USE OF HIF ALPHA STABILIZERS FOR ENHANCING ERYTHROPOIESIS |